Many complex diseases or traits are the results of both genetic and environmental factors. The environmental factors affect the human body by modifying its epigenetics, which controls the activity of genomes without mutating it. Viral infection is one of the common environmental factors for complex diseases. For example, the human immunodeficiency virus (HIV) infection can cause acquired immune deficiency syndrome (AIDS), HBV, and HCV infections are associated with hepatocellular carcinoma, and human papillomavirus infection is a causal factor in cervical carcinoma. In this study, to investigate how HIV infection affects DNA methylation, we analyzed the blood DNA methylation data of 485 512 sites in 44 HIV-and 142 HIV + patients. Several advanced computational methods were applied to identify the core distinctive features that were different between the HIV patients and the healthy controls. These methods can be used for differentiating HIV-infected patients from uninfected ones. These core distinctive DNA methylation features were confirmed to be functionally connected to premature aging and abnormal immune regulation, two typical pathological symptoms of HIV infection, revealing the potential regulatory mechanisms of HIV infection on the DNA methylation status of the host cells and provided novel insights on the pathogenesis of HIV infection and AIDS.
Introduction
The human immunodeficiency virus (HIV), a member of the lentivirus family, is a positive-sense, enveloped RNA virus [1, 2] . HIV leads to typical HIV infection in the short term and acquired immune deficiency syndrome (AIDS) in the long term. According to the statistics provided by the World Health Organization, only in 2016, approximately 1.8 million people were newly infected with HIV, and more than 1 million people died from HIV-associated diseases and complications, indicating that HIV infection and AIDS induced by HIV have already become one of the biggest threats to human health [3, 4] . With the development of Highly Active Anti-Retroviral Therapy (HAART), the worldwide HIV mortality has greatly dropped off. Only in 2010 one year, more than 700,000 lives were survived by HAART, reflecting the great progression in such research field.
The major pathogenesis of HIV infection and AIDS is closely related to immune regulatory and effective cells, including CD4 + and CD8 + T cells [5] [6] [7] . Artificially, the pathogenic processes can be divided into three stages: (1) primary HIV infection, (2) chronic asymptomatic HIV infection, and (3) late stage HIV infection [8] . In the first stage, the rapid infection of HIV virus induces a specific viremic peak associated with the depletion of CD4 + T cells [9] . With the activation of cellular immune reaction, the replication of HIV is gradually controlled, and the pathogenesis turns into the chronic stage, the second stage. This stage of HIV infection induces a highly dynamic and persistent viral replication. Such replication and HIV-specific cellular immune reaction further lead to an increased depletion of CD4 + T cells in this stage [10] . Finally, with the count of CD4 + T cells reducing to <200 × 10 9 /L, the pathogenesis of HIV enters the late stage. In such stage, large amounts of viruses are produced each day, causing the decline of CD4 + T cells. However, such elimination of CD4 + T cells cannot be further attributed to CD8 + T cellmediated cellular immune responses, but the direct viral Tcell-killing mechanism induced by rapid proliferation of virus in cells, reflecting the distinctive pathogenic mechanisms in different HIV infection stages [8] . As mentioned above, HAART turns out to be one of the major and the most effective therapeutic approaches for HIV infection. Such pathogenic effects of HIV infection can be interrupted by the use of HAART, leading to the remission of AIDs.
During the complicated infection and progression processes of HIV, the single-stranded viral RNA genome is reversely transcribed, and the double-stranded viral DNA integrates into the cellular DNA, forming a provirus. According to recent publications [11, 12] , the integration of HIV is quite similar to DNA transposition and may induce various specific genetic and epigenetic alterations, including genomic integration-induced host genomic instability [13] , host epigenetic status alteration [14] , and altered gene transcription and splicing regulation [15] . Early in 2010, a study on the DNA methylation status of B lymphoma confirmed that HIV infections may induce novel epigenetic changes, including DNA methylation status alteration of specific functional sites [16] . In 2015, a whole-genome DNA methylation array [14] revealed that HIV-1 infection may affect the DNA methylation status of IGFBP6 and SATB2, thus downregulating their expression, which validates the potential contribution of HIV infection on genomic modification. In 2017, a study [17] on the pathogenic mechanisms of HIV-1 RNA survival in the host cell during infection confirmed that HIV hijacks the RNA processing machinery within the stress granules to ensure its own survival in the host cell via regulations on the genomic DNA methylation status of certain genes. Overall, according to these studies, HIV may regulate the specific DNA methylation status of functional genes in the host cells for its own survival and proliferation.
During the chronic HIV infection status (the second stage), HIV has a unique highly dynamic and persistent viral replication, inducing frequent genomic integration and may have more effects on the DNA methylation status of the host genome. The effects of HIV infection have been studied by several groups. Gross et al. [18] found that the HIV infection makes the DNA methylation profiles of patients look 4.9 years older than their actual ages. Thus, the DNA methylation profiles are good predictors for premature aging [19] . Deeks [20] reported that the immunologic abnormalities caused by HIV are similar to the adaptive immune system changes in elderly people. All these studies have shown that the HIV infection has huge impact on systemic immune activation [21] , possibly through epigenetic mechanisms [18] . To verify these biological hypotheses about the effects of HIV infections on DNA methylation, we presented a novel computational method to identify the typical and discriminative DNA methylation sites induced by HIV infections. By employing several advanced computational methods, on one hand, we identified the core distinctive features that may distinguish the HIV patients from the healthy controls; on the other hand, the core distinctive DNA methylation features we screened out may systematically reveal the potential regulatory mechanisms of HIV infection on the DNA methylation status of the host cells and their potential contributions on two typical symptoms of HIV infection, premature aging, and abnormal immune regulation on the DNA methylation level, supplementing previous studies on the pathogenesis of HIV infection and AIDS.
Materials and methods

Dataset
We downloaded the whole-blood DNA methylation data of 485,512 sites in 44 HIV -and 142 HIV + patients from the Gene Expression Omnibus (GEO) with accession number of GSE67705 [18] . We investigated the DNA methylation difference between HIV -and HIV + patients using advanced computational methods to identify the DNA methylation biomarker of HIV infection.
Feature selection
The purpose of feature selection is to obtain the optimum features for distinguishing samples between HIV -and HIV + patients. In this study, all patients were represented by 485,512 features (sites), which made the extraction of optimum features difficult. Here, we first employed mutual information (MI) to evaluate the importance of each feature and select key features and then the Monte Carlo feature selection (MCFS) [22] and incremental feature selection (IFS) [23] were adopted to detect interpretable rules and optimum genes for classifying HIV -patients from HIV + patients.
Selecting important features using MI
Among the 485,512 features, some features may be highly related to the label of HIV -and HIV + patients, that is, they may provide important contribution for classifying samples between these two patients. MI is a classic measurement to evaluate the mutual dependence between two variables in probability and information theory. Compared to the correlation coefficient, it has wider applications because it can process non-real-valued variables. Furthermore, a publication has been proved that MI has better performance than the correlation coefficient [24] . In view of this, MI was employed to extract important features and is defined as below:
Iðx; yÞ ¼ ZZ pðx; yÞ log pðx; yÞ pðxÞpðyÞ dxdy ð1Þ
where p(x) and p(y) indicate the marginal probabilistic density of x and y, respectively, and p(x,y) represents the joint probabilistic density of x and y.
Here, let c be the variable representing the labels of HIV -or HIV + patients. For each feature f, calculate the MI between it and c to indicate the importance of the feature. Clearly, a feature receiving a high MI should be selected for further analysis because it is highly related to the classification labels of HIV -and HIV + patients. By setting a threshold to MI, useless features can be discarded, and important ones are selected. The selected features were further analyzed using the MCFS method described in the following section.
Monte Carlo feature selection
For the remaining features, a feature selection method should be employed to analyze them and help us select important ones. To date, lots of feature selection methods, such as minimum redundancy maximum relevance [25] , maximum relevance maximum distance [26] , ReliefF [27] , etc. have been proposed. Different methods have their own advantages. Considering that the number of samples investigated in this study was only 186 while the number of features were more than 10,000, thus the feature matrix representing 186 samples had a large column number and a small row number. For this type of data, a recent proposed feature selection method, named MCFS [22] , has been proved to be good at dealing with it. Up to now, it has been applied to deal with different biological problems [28] [29] [30] [31] [32] .
MCFS trains multiple decision trees on bootstrap samples and randomly selected feature subsets with m features from the original M features (m≪ M). For each feature subset, p decision trees are trained and evaluated on p bootstrap training sets consisting of samples with this feature subset. Suppose this process is repeated t times; we can obtain t feature subsets and p × t decision trees.
A score called relative importance (RI) is defined as the importance based on how a feature is performed in each constructed decision tree classifier. The RI score of feature g is defined as
where t is the number of feature subsets, and p is the number of bootstrap subsets. wAcc is the weighted accuracy, calculated by the mean sensitivity of all decision classes. n g (τ) indicates the number of a node involved in decision tree τ using feature g. IG(n g (τ)) is the information gain of n g (τ), no.in τ is the number of samples in decision tree τ, and no.in n g (τ) is the number of training samples in node n g (τ). Finally, u and v are two weighting factors that determine wAcc's importance and the number of samples in the node n g (τ).
Clearly, a feature with a high RI score means it is quite important for distinguishing samples from different groups. Thus, according to the RI scores of all features, a feature list can be constructed by ranking features with decreasing order of their RI scores. Here, the obtained feature list is formulated as
where N represents the number of investigated features.
Incremental feature selection
IFS [23] is primarily used to screen a set of optimal features to accurately distinguish samples from different groups. In this study, IFS is performed on the feature list (cf. Eq. 3) generated by MCFS. To accelerate the procedures for finding optimal features, feature subsets with larger step sizes (e.g., 10 steps) are constructed. According to the feature list F in Eq. 3, [N/10] feature subsets are constructed as F 1 ,F 2 ,..,F [N/10] , where the i-th feature subset contains the top 10 × i features in F, that is,
; f 10Âi g. Then, we test these feature subsets by constructing and evaluating support vector machine (SVM) classifiers. A feature subset with the best performance can be found, and the features inside this feature subset are called optimal features, whereas the corresponding classifier is termed as the optimal classifier.
Support vector machine
SVM [33] is a supervised learning algorithm based on statistical learning theory and has been widely used in biological problems [29] [30] [31] [34] [35] [36] [37] [38] [39] [40] . Its basic principle is to map data into a high-dimensional linear space using kernel trick (such as Gaussian kernel) and then fit the linear function on this high-dimensional space. SVMs infer a hyperplane with the maximum margin between the two classes of samples. The generalization error becomes lower when the margin becomes larger. SVMs can handle not only linear classification problem but also nonlinear classification problem.
In this study, we employed the classifier "sequential minimal optimization" (SMO) in Weka [41] , a suite of software collecting several popular machine learning algorithms. The classifier implements one type of SVM that is trained using SMO algorithm [42, 43] . For convenience, this classifier was executed using its default parameters.
Performance measurement
In this study, we applied 10-fold cross-validation [44] [45] [46] [47] [48] [49] [50] to evaluate the classification performance of classifying HIVpatients from HIV + ones. As a binary classification problem, four metrics are usually calculated, that is, sensitivity (SN), specificity (SP), accuracy (ACC) [51] [52] [53] [54] , and Matthew's correlation coefficient (MCC) [55] , to evaluate the performance of trained models. These measurements can be calculated by the following formulas:
where TP represents the number of positive samples that are correctly predicted, FP represents the number of negative samples that are incorrectly predicted to be positive samples, TN represents the number of negative samples that are correctly predicted, and FN represents the number of positive samples that are incorrectly predicted to be negative samples. MCC is a balanced measurement further considering the number of positive and negative samples. It ranges from −1 to 1. Considering that the HIV + patients were more than three times as many as HIV -patients, that is, the investigated dataset was imbalanced, MCC was selected as the primary measurement to evaluate the prediction ability of classifiers.
Results
In this study, we proposed a computational method incorporating several advanced computational techniques to analyze the whole-blood DNA methylation data of HIV + and HIV -patients. The whole procedures are illustrated in Fig. 1 . This section gave detailed results of each stage in our method.
For the 485,512 sites used to represent HIV + and HIVpatients, we first evaluated them using MI values mentioned in Section "Selecting important features using MI". As a result, a threshold of 0.1 was set to MI value, that is, sites with MI values larger than 0.1 were selected. We obtained 24,402 sites, which are listed in Supplementary Material S1.
For the remaining 24,402 sites, we then used MCFS to further evaluate them. Each site was assigned an RI score, which is also provided in Supplementary Material S1. According to these RI scores, a feature list F was constructed as formulated in Eq. 3, which is available in Supplementary Material S1.
To further extract important features that can indicate the DNA methylation difference of HIV + and HIV -patients, the IFS method mentioned in Section "Incremental feature selection" was employed. This method generates a series of feature subsets with 10 steps according to the feature list F. Then, the SVM classifier is trained and evaluated on samples represented by features from each constructed feature subset by using 10-fold cross-validation. Predicted results are counted as four measurements described in Section "Performance measurement", which are all listed in Supplementary Material S2. To clearly exhibit the results, we plot a curve by using the MCC as its y-axis and the number of features used as its x-axis, as shown in Fig. 2(a) . The MCC reaches high values when using some top rank features in F. In detail, the MCC is 0.985 when the top 10 features were used. Thus, we further amplify the curve between x-axis 10 and 200, as shown in Fig. 2(b) . We obtain an MCC of 100%, indicating perfect classification, when using only top 140 features. However, because we used step ten to construct the feature sets and tested them, it is possible that using less than 140 features can still produce perfect classification. Thus, we further tested the feature sets consisting of top 1-140 features in the feature list. The obtained SNs, SPs, ACCs, and MCCs are also provided in Supplementary Material S2. Also, to give a clear description of MCC trends corresponding to the number of used features, an IFS curve was also plotted, as shown in Fig. 3 . It can be observed that the top 138 features can also produce perfect classification (MCC = 100%). Thus, we determined the top 138 features in F as optimal features, and the corresponding SVM classifier was the optimal classifier.
Based on the program of MCFS, some informative features can be obtained, which were some top features in the feature list. Then, the program can further produce three classification rules, listed in Table 1 , which in fact is generated by the Johnson Reducer algorithm [56] and Repeated Incremental Pruning to Produce Error Reduction (RIPPER) algorithm [57] . We applied these three rules to classify HIV -patients from HIV + ones. We achieved a predicted accuracy of 0.921, a weighted accuracy of 0.899, an MCC of 0.785 by running 10-fold cross-validation three times. Although these rules yielded a lower accuracy than SVM, they can provide a clearer outline of the DNA methylation differences between HIV + and HIV -patients.
Discussion
In this study, we applied several advanced computational methods to extract key DNA methylation sites that are induced by and may be functionally associated with the chronic pathogenesis of HIV infection. According to the results listed in "Results" Section, we not only identified a group of highly related genes that may have unique DNA methylation status in HIV infection status compared with physical ones but also set up a group of quantitative rules for further detailed discrimination of HIV-infected patients and normal controls. Among the 138 optimal features, several of them can be supported by recent publications. Considering that the MCC reached 0.985 when the top 10 features were used, which can be the backbone of optimal features, these 10 features are extensively analyzed in Section "Analysis of optimal HIV infection-associated genes/DNA methylation regions". Some recent publications can also provide support for the quantitative rules listed in Table 1 , which are analyzed in Section "Analysis of quantitative rules for the discrimination of HIV infection patients and normal controls". In addition, some optimal features were related to genes that can participate in HIV-induced premature aging and immune regulation on the DNA methylation level, indicating their irreplaceable roles and peculiar contributions on HIV-induced pathogenesis. Fig. 1 The procedures to analyze the whole-blood methylation data of HIV + and HIV -patients. First, each feature was evaluated by measuring its associations to target variable via mutual information (MI), features with MIs larger than 0.1 were selected. Second, the selected features were analyzed by Monte Carlo feature selection (MCFS) method, resulting in a feature list and some informative features that were some top features in the above list. Third, for the feature list, the incremental feature selection (IFS) and support vector machine (SVM) methods were adopted to extract optimal features and construct optimal classifier. Finally, for informative features, the MCFS program, integrating the Johnson Reducer algorithm and Repeated Incremental Pruning to Produce Error Reduction (RIPPER) algorithm, generated some classification rules
Analysis of optimal HIV infection-associated genes/ DNA methylation regions
This section provides an extensive analysis of the top 10 features produced by MCFS method, which are listed in Table 2 . The first identified probe cg00676801 tests the DNA methylation status of the 5′ untranslated region of STAT1. According to recent publications, another functional gene named PRMT1 has been confirmed to promote the transcription of HIV-associated genes through the DNA methylation of STAT1 by preventing the association with the STAT-inhibitor PIAS1 [58, 59] . Therefore, it is quite reasonable to identify the DNA methylation status of STAT1 as a potential discriminative marker for HIVinfected patients. Similarly, the next probe cg07839457 may also have different DNA methylation status in HIV patients and normal controls. According to our dataset, such probe is generally used for the identification of the DNA methylation status of a unique functional gene named NLRC5. Regulating the major histocompatibility complex class I restricted immune recognition [60] . Such gene has been identified to have distinctive DNA methylation status between HIV-infected and uninfected individuals according to a recent epigenome-wide study [61] . Another study has already regarded the NLRC5 gene as a potential epigenetic target for curing HIV infection [62] . Coincidentally, the sixth optimal gene with probe cg16411857 also turns out to be NLRC5 with different probe overlapping regions. However, it has similar DNA methylation indicator functions. As analyzed above, NLRC5 has a unique DNA methylation pattern in HIV patients.
The third, fourth, and seventh optimal probes (cg26573274, cg24430034, and cg05616584) have not been annotated with accurate gene symbols according to the dataset provided by DNA methylation chip probe platform. The cg26573274 and cg24430034 probes are designed to detect the DNA methylation status in a specific intergenic region on chromosome 13 (chr13: 109184050-109184369) according to GRCh37. Such region has been confirmed to be located between the coding region of genes HCFC2P1 and MYO16. The DNA methylation status of such region may directly/indirectly affect the expression pattern of such two genes and is involved in the pathogenesis of HIV infection. During the pathogenesis of HIV infection, the DNA methylation status of HCFC2P1 [14, 63] and MYO16 [64] may be abnormally regulated due to their specific biological functions on DNA replication [64] , indicating that the DNA methylation status of such site may also be a potential biomarker for the distinction of HIVinfected patients from healthy populations. Therefore, such DNA methylation region detected by two specific probes is a potential detection marker for differentiating HIV-infected patients from uninfected ones. The seventh optimal probe cg05616584 is designed for the detection of DNA methylation status on chromosome 5 (chr5: 133449320-133451260) around the coding region of various infections, especially HIV infection-associated genes, including TNIP1 [65] and DCLK1 [66] . The DNA methylation status of peripheral regions around functional genes has an irreplaceable effect on the expression pattern of such genes directly. Therefore, the DNA methylation status of such screened out regions on chromosome 5 may be indirectly related with the infection status of HIVs mediated by genes such as TNIP1 and DCLK1.
The following probe named cg15582789 is designed for the detection of gene SLC35D2's DNA methylation status. As a functional nucleotide sugar transporter, such gene participates in growth factor signaling and sugar metabolism pathways [67] . As for its relationship with HIV infection, recent studies on anti-HIV drugs implied that the nucleotide sugar transport regulated by an abnormal SLC35D2 expression level in HIV patients contributes to the maintenance of HIV life cycle in the host cells and is involved in HIV infection-associated neurocognitive disorders [68, 69] . The DNA methylation status of a unique gene may affect further transcription and translation of such gene and its downstream products such as mRNAs and proteins [70] . Therefore, such DNA methylation site may also be a potential detective region for the identification of HIV patients from healthy populations. The next probe named cg27190138 detects the DNA methylation status of the PIK3AP1 gene and has also been predicted to be discriminative in HIV patients and normal controls. As a regulator for the innate immune system and GAB1 signalosome, such gene participates in the immune reactions against viruses, including Epstein-Barr virus and human papillomavirus [71] . According to the pathological studies on HIV infection processes, the innate immune reactions have been gradually suppressed by specific viral regulation on either nucleotide or protein level together with the expression of related genes [72] [73] [74] . Based on previous studies [75, 76] , the DNA methylation status of innate immune-associated genes such as PIK3AP1 may definitely affect the survival and proliferation of HIVs in the host cells, indicating that people with different DNA methylation/ expression levels of such gene (patients and healthy individuals) may have different HIV load. Probes detected by numbers cg01485645 and cg10482201 have been screened out for the distinctive identification of HIV patients from the healthy population. MLLT6 and ZNF597 are the targets for the two probes, implying that these two genes may have unique DNA methylation patterns in HIV patients compared with health individuals. As a regulator for blood cell development, MLLT6 has a different DNA methylation status in different blood cellular components such as T cells [77] .
Considering that the proportion of immune components in the peripheral blood system may be roughly altered during HIV infection, the average DNA methylation status of MLLT6 may also be discriminative in HIV patients compared with healthy controls. ZNF597 also participates in T cell-mediated cellular immune response [78] . The DNA methylation of such gene is highly expressed in the lymph nodes and spleen, where T cells aggregate, corresponding with the typical symptom of HIV infections [79] . Therefore, it is quite reasonable to speculate that the DNA methylation status of such gene may be directly related with the HIV-induced T cell dysfunction, and therefore, such region is regarded as a potential DNA methylation biomarker for the identification of HIV patients. In summary, according to recent publications, several identified DNA methylation sites, marked by each candidate probe, can be confirmed to be qualitatively related to HIV infection and may be potential biomarkers for differentiating HIV-infected patients from uninfected ones, corresponding with our results.
Analysis of quantitative rules for the discrimination of HIV infection patients and normal controls
Apart from the above qualitative markers, three quantitative rules listed in Table 1 were produced by the program of MCFS and provided a clearer recognition of HIV + patients from HIV -ones. Three features were involved in these three rules and their ranks in the feature list yielded by the MCFS method are 1, 32, and 6 (see Table 1 ), respectively, implying they can really mark the differences between HIV + and HIV -patients.
The first rule involves two DNA methylation sites, STAT1 and LOC338758, marked by probes cg00676801 and cg15104066. As mentioned above, STAT1 is downregulated during the pathological processes of HIV infection mediated by PRMT1, aiming at the upregulation of functional genes that are essential for the survival and proliferation of HIVs [58, 80] . Furthermore, such gene may negatively modulate the transmission of HIV inside the circulating system, indicating that the upregulation of such gene just corresponding with this rule may indicate a low risk on HIV infection progression [80] . As for LOC338758, according to the datasets provided by GEO profiles, the expression of such gene is upregulated in various HIV infection patients [81, 82] . The second rule involves another functional gene named NLRC5 (cg16411857). As analyzed above, the high expression level of such gene may inhibit the ordinary innate immune and humoral immune reactions [61] . Therefore, it is quite reasonable to speculate that the high DNA methylation or, in other words, low expression of such gene in immune cells may indicate a low risk of HIV infection. Patients with DNA methylation status discrepant with the two rules may be HIV-infected patients, with an accuracy higher than 92%.
Internal relationship between HIV infectionassociated genes/DNA methylation regions and premature aging or immune regulation
In 2016, Gross et al. [18] found that the HIV infection makes the DNA methylation profiles of patients look 4.9 years older than their actual ages. And it has been reported by multiple publications that the DNA methylation profiles are good predictors for premature aging [19] . Furthermore, an early study reported by Deeks [20] showed that the immunologic abnormalities caused by HIV are similar to the adaptive immune system changes in elderly people. All these studies have shown that the HIV infection has huge impact on systemic immune activation [21] , possibly through epigenetic mechanisms [18] .
According to recent publications, the optimal genes we screened out and analyzed above have also be functionally related to premature aging or immune regulation, further validating their functional relationship with HIV DNA methylation. For instance, gene NLRC5 has been shown to be directly functionally related to premature aging. According to the database, named Human Ageing Genomic Resources (HAGR), the optimal gene NLRC5 has been shown to affect the lifespan on the single nucleotide polymorphism level [83] , helping demonstrate the potential lifespan influential mechanisms of HIV infection. Apart from NLRC5, another mentioned gene DCLK1 has also been shown to be possibly related to ageing, corresponding with such speculation above. According to an Italian study [84] , DCLK1 has been identified by a genome-wide associated study on 410 long-live individuals. Therefore, as we have analyzed above, HIV DNA methylation associated genes have been shown to be functionally related with ageing associated biological processes, validating such identified DNA methylation markers are good predictors for premature aging and revealing the potential relationship between HIV infection and ageing.
Apart from the potential relationship between HIV infection and ageing, such identified HIV infection regions/ genes at the DNA methylation level have also been reported to be functionally related to immune regulation, corresponding with the previous speculations above. STAT1, as we have mentioned above, has been shown to have quite significant immune regulation potentials. According to recent publications, STAT1 has been shown to dominate STAT1-dependent proinflammatory phenotype in monocytes, constructing a typical immune regulatory mechanism in HIV infection pathogenesis [85, 86] . Apart from that, MLLT6, as we have mentioned above, has already be discussed and confirmed to be functionally related to T-cell dependent immune response, further validating our speculation. Therefore, summarizing such analysis above, HIV infection-associated genes at the DNA methylation level tend to perform peculiar roles in ageing and immune regulation, corresponding with the specific immune and ageing impact on and relationship with HIV infection.
In this study, based on the DNA methylation statistics of HIV patients and normal controls, we applied several computational methods for the identification of HIV infection-associated DNA methylation sites and a series of quantitative rules for the accurate recognition of HIVinfected patients based on their m DNA methylation status. Several identified DNA methylation sites and rules can be verified by recent publications as analyzed above, validating the reliability of the obtained results. Such optimal DNA methylation sites and genes have been further shown to participate in immune regulation and premature aging associated biological processes, corresponding with typical HIV-associated symptoms.
